Retinoid metabolism in the prostate: Effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide

Cancer Research

Volumn 59, Issue 23, 1999, Pages 5947-5955

  Lewis, Kevin C ^a   Hochadel, James F ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENRETINIDE; RETINOID;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DYNAMICS; ESTERIFICATION; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MALE; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; PROSTATE; QUANTITATIVE ASSAY; RAT; TISSUE CULTURE; VITAMIN METABOLISM;

ANIMALS; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; FENRETINIDE; HUMANS; KINETICS; MALE; MODELS, BIOLOGICAL; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; RETINOIDS; TISSUE DISTRIBUTION; VITAMIN A;

EID: 0033460196     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Moon, R. C., Thompson, H. J., Becci, P. J., Grubbs, C. J., Gander, R. J., Newton, D. L., Smith, J. M., Phillips, S. L., Henderson, W. R., Mullen, L. T., Brown, C. C., and Sporn, M. B. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res., 39: 1339-1346, 1979.
2. Moon, R. C. Comparative aspects of carotenoids and retinoids as chemopreventive agents for cancer. J. Nutr., 119: 127-134, 1989.
3. Moon, R. C., Mehta, R. C., and Rao, K. V. M. Retinoids and cancer in experimental animals. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine. Ed. 2, pp. 573-593. New York: Raven Press, 1994.
4. Formelli, F., Barua, A., and Olson, J. A. Bioactivities of N-(4-hydroxyphenyl)retinamide and retinoyl B-glucuronide. FASEB J., 10: 1014-1024, 1996.
5. Kaiser-Kupfer, M. I., Peck, G. L., Caruso, R. C., Jaffe, M. J., DiGiovanna, J., and Gross, E. G. Abnormal retinal function associated with fenretinide, a synthetic retinoid. Arch. Ophthalmol., 104: 69-70, 1986.
6. Kingston, T. P., Lowe, N. J., Winston, J., and Heckenlively, J. Visual and cutaneous toxicity which occurs during N-(4-hydroxyphenyl)retinamide therapy for psoriasis. Clin. Exp. Dermatol., 11: 624-627, 1986.
7. Costa, A., Malone, W., Perloff, M., Buranelli, F., Campa, T., Dossena, G., Magni, A., Pizzichetta, M., Andreoli, C., Del Vecchio, M., Formelli, F., and Barberi, A. Tolerability of the synthetic retinoid fenretinide (HPR). Eur. J. Cancer Clin. Oncol., 25: 805-808, 1989.
8. Modiano, M. R., Dalton, W. S., Lippman, S. M., Joffe, L., Booth, A. R., and Meyskens, F. L. Phase II study of fenretinide in advanced breast cancer and melanoma. Investig. New Drugs, 8: 317-319, 1990.
9. Gross, E. G., and Helfgolt, M. A. Retinoids and the eye. Dermatol. Clin., 10: 521-531, 1992.
10. Decensi, A., Torrisi, R., Polizzi, A., Gesi, R., Brezzo, V., Rolando, M., Rondanina, G., Orenga, M. A., Formelli, F., and Costa, A. Effects of the synthetic retinoid fenretinide on dark adaptation and the ocular surface. J. Natl. Cancer Inst., 86: 105-110, 1994.
11. Mariani, L., Formelli, F., DePalo, G., Manzari, A. Carnerini, T., Campa, T., DiMauro, M. G., Crippa, A., Delle Grottaglie, M., Del Vecchio, M., Marubini, E., Costa, A., and Veronesi, U. Chemoprevention of breast cancer with fenretinide (4-HPR): study of long-term visual and ophthalomologic tolerability. Tumori, 82: 444-449, 1996.
12. Kelloff, G. J., Crowell, J. A., Boone, C. W., Steele, V. E., Lubet, R. A., Greenwald, P., Alberts, D. S., Covey, J. M., Doody, L. A., Knapp, G. G., Nayfield, S., Parkinson, D. R., Prasad, V. K., Prorok, P. C., Sausville, E. A., and Sigman, C. C. Clinical development plan: N-(4-hydroxyphenyl)retinamide. J. Cell. Biochem. Suppl., 20: 176-196, 1994.
13. Supino, R., Crosti, M., Clerici, M., Walters, A., Cleris, L., Zunio, F., and Formelli, F. Induction of apoptosis by fenretinide (4-HPR) in human ovarian carcinoma cell and its association with retinoic acid receptor expression. Int. J. Cancer, 65: 491-497, 1996.
14. Fanjul, A. N., Delia, D., Pierotti, M. A., Rideout, D., Qui, J., and Phahl, M. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J. Biol. Chem., 271: 22441-22446, 1996.
15. Sheikh, M. S., Shao, Z. M., Li, X. S., Ordonez, J. V., Conley, B. A., Wu, S., Dawson, M. I., Han, Q. X., Chao, W. R., Quick, T., Niles, R. M., and Fontana, J. A. N-(4-Hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Carcinogenesis (Lond.), 16: 2477-2486, 1995.
16. Oridate, N., Suzuki, S., Higuchi, M. Mitchell, M. F., Hong, W. K., and Lotan, R. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. J. Natl. Cancer inst., 89: 1191-1198, 1997.
17. Delia, D., Aiello, A., Meroni, L., Nicolini, M., Reed, J. C., and Pierotti, M. A. Role of antioxidants and intracellular free radicals in retinamide-induced cell death. Carcinogenesis (Lond.), 18: 943-948, 1997.
18. Maurer, B. J., Metelisa, L. S., Seeger, R. C., Cabot, M. C., and Reynolds, C. P. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)retinamide in neuroblastoma cell lines. J. Natl. Cancer Inst., 91: 1138-1146, 1999.
19. 14C-labeled vitamin A and β-carotene in the rat. J. Biol. Chem., 240: 2839-2844, 1965.
20. Lewis, K. C., Zech, L. A., and Phang, J. M. Effects of N-(4-hydroxyphenyl)retinamide supplementation on vitamin A metabolism. Cancer Res., 54: 4112-4117, 1994.
21. Wilson, A. P. Cytotoxicity and viability assays. In: R. I. Freshney (ed.). Animal Cell Culture: A Practical Approach, pp. 200-205. Oxford: IRL Press, 1986.
22. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82: 1107-1112, 1990.
23. Rubinstein, L. V., Shoemaker, R. H., Paull, K. D., Simon, R. M., Tosini, S., Skehan, P., Scudiero, D. A., Monks, A., and Boyd, M. R. Comparison of in vitro anticancer drug screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J. Natl. Cancer Inst., 82: 1113-1118, 1990.
24. Mosmann, T. Rapid color assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods, 65: 55-63, 1983.
25. Hansen, H. B., Nielsen, S. E., and Berg, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killing. J. Immunol. Methods, 119: 203-210, 1989.
26. Berman, M., and Weiss, M. F. SAAM Manual: SAAM27 Version. DHEW Publication No. (NIH) 78-180. Washington, DC: U. S. Government Printing Office, 1978.
27. Berman, M., Beltz, W. F., Greif, P. C., Chabay, R., and Boston, R. C. CONSAM User's Guide. PHS Publication No. 1983-421-132: 3279. Washington, DC: U. S. Government Printing Office, 1983.
28. Foster, D. M. and Boston, R. C. The use of computers in compartmental analysis: The SAAM and CONSAM programs. In: J. S. Robertson (ed.), Compartmental Distribution of Radiotracers, pp. 73-142. Boca Raton, FL: CRC Press Inc., 1983.
29. Lewis, K. C., Zech, L. A., and Phang, J. M. Effects of chronic administration of N-(4-hydroxyphenyl)retinamide (4-HPR) in rats on vitamin A metabolism in the eye. Eur. J. Cancer, 32: 1803-1808, 1996.
30. Snedecor, G. W., and Cochran, W. G. Statistical Methods, Ed. 6, pp. 549. Ames, IA: Iowa State University Press, 1967.
31. Ball, M. D., Furr, H. C., and Olson, J. A. Enhancement of acyl coenzyme A: retinol acyltransferase in rat liver and mammary tissue by retinyl acetate and its competitive inhihition by N-(4-hydroxyphenyl)retinamide. Biochem. Biophys. Res. Commun., 128: 7-11, 1985.
32. Matsuura, T., Zhao, Z., and Ross, A. C. N-(4-Hydroxyphenyl)retinamide increases lecithin:retinol acyltransferase activity in rat liver. J. Nutr., 126: 2474-2480, 1996.
33. Dew, S. E., Wardlaw, S. A., and Ong, D. E. Effects of pharmacological retinoids on several vitamin A-metabolizing enzymes. Cancer Res., 53: 2965-2569, 1993.
34. Lewis, K. C., Green, M. H., and Underwood, B. A. Vitamin turnover in rats as influenced by vitamin A status. J. Nutr. 111: 1135-1144, 1981.
35. Green, M. H., Uhl, L., and Green, J. B. A multicompartmental model of vitamin A kinetics in rats with marginal vitamin A stores. J. Lipid Res., 26: 806-818, 1985.
36. Green, M. H., Green, J. B., and Lewis, K. C. Variation in retinol utilization rate with vitamin A status in the rat. J. Nutr., 117: 694-703, 1987.
37. Lewis, K. C., Green, M. H., and Zech, L. A. Retinol metabolism in rats with low vitamin A status: a compartmental model. J. Lipid Res., 31: 1535-1548, 1990.
38. Guo, X., and Gudas, L. J. Metabolism of all-trans-retinol in human cell strains and squamous cell carcinoma (SCC) lines from the oral cavity and skin: reduced esterification of retinol in SCC lines. Cancer Res., 58: 166-176, 1998.
39. Mehta, R. R., Hawthorne, M. E., Graves, J. M., and Mehta, R. G. Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells. Eur. J. Cancer, 34: 902-907, 1998.
40. Nomura, A. M. Y., and Kolonel, L. N. Prostate cancer: a current perspective. Am. J. Epidemiol., 13: 200-227, 1991.
41. McNeal, J. E. Regional morphology and pathology of the prostate. Am. J. Clin. Pathol., 49: 347-357, 1968.
42. Horozewicz, J. S., Leong, S. S., Chu, T. M., Wajsman, Z. L., Friedman, M., Papsidero, L., Kim, J., Chai, L. S., Kakati, S., Arya, S. K., and Sandberg, A. A. The LNCaP cell line - a new model for studies on human prostatic carcinoma. In: G. P. Murphy (ed.), Models for Prostate Cancer, pp. 115-132, New York: Alan R. Liss, Inc., 1980.
43. Pasquali, D., Thaller, C., and Eichele, G. Abnormal level of retinoic acid in prostate cancer tissues. J. Clin. Endocrinol., 81: 2186-2191, 1996.
44. Boyd, D. L., Chisholm, G. D., and Habib, F. K. Nuclear retinoic acid binding protein in human prostate adenomas. J. Endocrinol., 105: 157-162, 1985.
45. Jutley, J. K., Kellher, J., Whelan, P., and Mikel, J. Cytosolic retinoic acid-binding protein in human prostatic dysplasia and neoplasia. Prostate, 11: 127-132, 1987.
46. Boylan, J. F., and Gudas, L. J. The level of CRABP-I expression influences the amounts and types of all-trans retinoic acid metabolites in F9 tetracarcinoma stem cells. J. Biol. Chem., 267: 21486-21491, 1992.
47. Sani, B. P., Shealy, Y. F., and Hill, D. L. N-(4-Hydroxyphenyl) retinamide: interactions with retinoid-binding proteins/receptors. Carcinogenesis (Lond.), 16: 2531-2534, 1995.
48. Adamson, P. C., Boylan, J. F., Balis, F. M., Murphy, R. F., Goodwin, K. A., Gudas, L. J., and Poplack, D. G. Time course induction of metabolism of all-tras-retinoic acid and the up-regulation of cellular retinoic acid-binding protein. Cancer Res., 53: 472-476, 1993.